While these factors and height are associated with PSA testing behaviour, only obesity and current smoking are differentially associated with PCa risk by tumour aggressiveness, specifically by having a negative association with non-aggressive/localised PCa, which is typically PSA-detected. The gene discussed is KLK3; the disease is obesity disorder.